Israeli Healthtech Venture Fund Sees Industry ‘Revolution’
This article is for subscribers only.
Israel’s biggest venture investor in health technology sees “a couple” of its portfolio companies going public next year, as firms prepare to cash out after the pandemic boosted their valuations.
aMoon, which manages $1.1 billion, already had several exits in 2020, including the initial public offering of Seer Inc., partner Tomer Berkovitz said in an interview. Shares in the California-based genomics company surged to $63 this week, valuing it at $3.7 billion, a nine-fold increase over the price of aMoon’s initial investment a year ago, he said.